MAXCYTE INC COM STK USD0.01 (DI)MAXCYTE INC COM STK USD0.01 (DI)MAXCYTE INC COM STK USD0.01 (DI)

MAXCYTE INC COM STK USD0.01 (DI)

No trades
See on Supercharts
Market capitalization
‪333.89 M‬GBP
‪−29.79 M‬GBP
‪32.43 M‬GBP
‪91.41 M‬
Beta (1Y)
2.10

About MAXCYTE INC COM STK USD0.01 (DI)

CEO
Maher Masoud
Headquarters
Rockville
Employees (FY)
143
Founded
1998
FIGI
BBG00CFTQNB2
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MXCT is 324 GBX — it has increased by 2.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MAXCYTE INC COM STK USD0.01 (DI) stocks are traded under the ticker MXCT.
MAXCYTE INC COM STK USD0.01 (DI) is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
MXCT stock is 2.87% volatile and has beta coefficient of 2.10. Check out the list of the most volatile stocks — is MAXCYTE INC COM STK USD0.01 (DI) there?
MXCT earnings for the last quarter are −0.09 GBX per share, whereas the estimation was −0.08 GBX resulting in a −8.98% surprise. The estimated earnings for the next quarter are −0.05 GBX per share. See more details about MAXCYTE INC COM STK USD0.01 (DI) earnings.
MAXCYTE INC COM STK USD0.01 (DI) revenue for the last quarter amounts to ‪6.56 M‬ GBX despite the estimated figure of ‪7.27 M‬ GBX. In the next quarter revenue is expected to reach ‪10.56 M‬ GBX.
Yes, you can track MAXCYTE INC COM STK USD0.01 (DI) financials in yearly and quarterly reports right on TradingView.
MXCT stock has risen by 4.16% compared to the previous week, the month change is a 8.50% fall, over the last year MAXCYTE INC COM STK USD0.01 (DI) has showed a 19.25% decrease.
MXCT net income for the last quarter is ‪−4.15 M‬ GBP, while the quarter before that showed ‪−9.23 M‬ GBP of net income which accounts for 55.06% change. Track more MAXCYTE INC COM STK USD0.01 (DI) financial stats to get the full picture.
Today MAXCYTE INC COM STK USD0.01 (DI) has the market capitalization of ‪333.89 M‬, it has increased by 0.11% over the last week.
No, MXCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MXCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAXCYTE INC COM STK USD0.01 (DI) stock right from TradingView charts — choose your broker and connect to your account.
MXCT reached its all-time high on Sep 10, 2021 with the price of 1236 GBX, and its all-time low was 72 GBX and was reached on Mar 29, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 143.00 employees. See our rating of the largest employees — is MAXCYTE INC COM STK USD0.01 (DI) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MAXCYTE INC COM STK USD0.01 (DI) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MAXCYTE INC COM STK USD0.01 (DI) stock shows the sell signal. See more of MAXCYTE INC COM STK USD0.01 (DI) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MAXCYTE INC COM STK USD0.01 (DI) future price: according to them, MXCT price has a max estimate of 889.25 GBX and a min estimate of 565.89 GBX. Read a more detailed MAXCYTE INC COM STK USD0.01 (DI) forecast: see what analysts think of MAXCYTE INC COM STK USD0.01 (DI) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MAXCYTE INC COM STK USD0.01 (DI) EBITDA is ‪−34.59 M‬ GBP, and current EBITDA margin is −106.68%. See more stats in MAXCYTE INC COM STK USD0.01 (DI) financial statements.